Compare BOLD & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BOLD | MOBX |
|---|---|---|
| Founded | 2018 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.9M | 22.0M |
| IPO Year | 2024 | N/A |
| Metric | BOLD | MOBX |
|---|---|---|
| Price | $1.28 | $0.24 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 119.5K | ★ 13.7M |
| Earning Date | 11-05-2025 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $10,984,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 180.13 |
| 52 Week Low | $1.00 | $0.17 |
| 52 Week High | $2.77 | $1.73 |
| Indicator | BOLD | MOBX |
|---|---|---|
| Relative Strength Index (RSI) | 61.70 | 35.26 |
| Support Level | $1.14 | $0.17 |
| Resistance Level | $1.24 | $0.40 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 62.00 | 26.00 |
Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.
Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.